Holen Sie sich die Stockscreener-App
1.975
7.94%
-0.165
Finanzdaten der Phio Pharmaceuticals Corp-Aktie (PHIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
16.32%
2.209
|
1.899 | 2.776 | 2.547 | 3.602 |
| Operating Income/Loss |
16.32%
-2.209
|
-1.899 | -2.776 | -2.547 | -3.602 |
| Nonoperating Income/Loss |
1,275%
0.055
|
0.004 | -0.004 | -0.002 | - |
| Income/Loss From Continuing Operations Before Tax |
13.67%
-2.154
|
-1.895 | -2.78 | -2.549 | -3.602 |
| Income/Loss From Continuing Operations After Tax |
13.67%
-2.154
|
-1.895 | -2.78 | -2.549 | -3.602 |
|
Net Income/Loss
|
13.67%
-2.154
|
-1.895 | -2.78 | -2.549 | -3.602 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,385%
4.5801
|
0.3085 | 2.4402 | 1,728.49 | 1.1422 |
| Diluted Average Shares |
1,385%
4.5801
|
0.3085 | 2.4402 | 1,728.49 | 1.1422 |
| Basic Earnings Per Share |
176.47%
-0.47
|
-0.17 | -1.14 | -1.47 | -3.15 |
| Diluted Earnings Per Share |
176.47%
-0.47
|
-0.17 | -1.14 | -1.47 | -3.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.36%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):